Replies to post #439781 on Anavex Life Sciences Corp (AVXL)

[sokol]

Thank you, that is helpful.

[xodcode]

All we really know so far is that Anavex stated sleep did not get worse by taking A2-73, no hard data published so far AFAIK. As in the open label P2 AD trial is not in my book hard data.

I guess that is why AVXL Anavex Life Sciences Announced Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Insomnia or AnxietyGrant of Its Newest U.S. Patent Expands Anavex’s Compounds Intellectual Property Portfolio.

C'mon, you know WGT!